BioCryst Pharmaceuticals is En Fuego....

Hey folks,

Look at BCRX go! The chart looked good, and the stock was technically sound. All it needed was a little more volume, which in this case was created by increase interest in the stock due to its announcement of the FDA approval for human testing phase of their flu drug Peramivir! Great job BCRX! From this point on, the success or failure of the human trials will determine BCRX's fate. If they disclose positive results, the stock is going to hit 30+. If not, its back down to $9. Time will tell. For now, ride the hype and enjoy the ride. I had purchased a small position a few on Monday (12/19/05) on strength of the chart (bought near mid 15's and I am planning on selling before the end of the day, hopefully at 17.50 or higher!)



BioCryst Pharmaceuticals Inc (BCRX - NASDAQ) 3 month chart: Current Price: $17.43